MUSTANG BIO, INC.
Pharmaceutical Preparations · WALTHAM · MA
Moderate confidence (50%)
Updated Oct 14, 2026, 12:03 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: MUSTANG BIO, INC. received a delisting notice from its exchange (Apr 15, 2026)
Timeline
Every material event, newest first. History is never overwritten.
MUSTANG BIO, INC. received a delisting notice from its exchange
Apr 15, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting of Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 15, 2026, Mustang Bio, Inc. (the Company ) received a notice from the Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) indicating that the bid price of the Company s common stock, par value $0.0001 per share ( Common Stock ), had closed below $1.00 per share for 30 consecutive business days and, as a result, the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which sets forth the minimum bid price requirement for conti…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker MBIO on Nasdaq.
- SEC CIK
- 0001680048
- Website
- —
- —
- Headquarters
- WALTHAM, MA
- Also known as
- —
- Legal entities
- MUSTANG BIO, INC.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
MUSTANG BIO, INC. — Pharmaceutical Preparations (SIC 2834) — WALTHAM, MA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting of Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 15, 2026, Mustang Bio, Inc. (the Company ) received a notice from the Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) indicating that the bid price of the Company s common stock, par value $0.0001 per share ( Common Stock ), had closed below $1.00 per share for 30 consecutive business days and, as a result, the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which sets forth the minimum bid price requirement for conti…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:30 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:13 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 12:01 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:29 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.